Trialect

Active

Advanced Visiting Fellowship in Hepatology and Digestive Oncology

Hôpital BEAUJON

Hôpital BEAUJON, 100 Boulevard du Général Leclerc, 92110 Clichy, FRANCE

Dr. Mohamed Bouattour is a medical specialist at Beaujon University Hospital in Clichy, France. He has been a practitioner since 2007, with board certifications in Gastroenterology, Hepatology, and Medical Oncology. His primary expertise lies in the management and research of liver tumors, including hepatocellular carcinoma (HCC) and cholangiocarcinoma. He has served as the principal investigator for several phase 1 to 3 clinical trials focusing on these conditions.

Dr. Bouattour is actively involved in both national and international scientific collaborations and has authored numerous publications in the fields of liver and cancer diseases. He is a member of prominent societies such as the European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Diseases (AASLD), the International Liver Cancer Association (ILCA), and the American Society of Clinical Oncology (ASCO)

Main Areas of Interest

This fellowship will focus on the following core areas within hepatology and oncology:

Primary Liver Tumors:

Focus on hepatocellular carcinoma (HCC) and cholangiocarcinoma.
Advanced diagnosis and management strategies for liver cancers.

Clinical Trial Design and Management:

Development and execution of Phase 1 to Phase 3 clinical trials in liver oncology.
Understanding protocols for clinical research involving liver tumors.

Multidisciplinary Care in Digestive Oncology:

Collaborative care models involving hepatologists, oncologists, radiologists, and surgeons.
Integrating medical, interventional, and surgical approaches.

Innovative Liver Cancer Treatments:

Exploring novel therapies, including targeted therapy, immunotherapy, and precision medicine for liver cancer.
Reviewing current and emerging clinical guidelines.

Specialties

Hepatology

Gastroenterology

Oncology

General Medicine

Techniques You Will Learn

Participants will gain limited hands-on experience in the following techniques (this is not a board certified fellowship; this is a visiting program to gain experience only):

Advanced Diagnostic Techniques for Liver Cancer:

Imaging modalities: MRI, CT, and PET scans specific to liver tumors.
Biomarker identification and interpretation for HCC and cholangiocarcinoma.

Interventional Oncology Procedures:

Techniques include transarterial chemoembolization (TACE), radiofrequency ablation (RFA), and radioembolization.

Clinical Trial Protocol Development:

Crafting study designs, implementing protocols, and managing patient cohorts in Phase 1-3 trials.
Best practices in ethical considerations and regulatory compliance for liver cancer trials.

Multidisciplinary Tumor Board Participation:

Collaborative decision-making processes in complex hepatobiliary cancer cases.
Reviewing case studies and presenting research data.

Curriculum

This is a sample curriculum and it can be customized

Week 1-2:
Introduction and Overview

Orientation and review of institutional protocols.
Understanding the epidemiology and clinical presentation of primary liver tumors.
Basics of imaging and liver function tests for tumor diagnosis.

Week 3-4:
Diagnosis and Staging

Limited Hands-on sessions with imaging and pathology teams to learn staging techniques.
Detailed study of biomarkers and diagnostic criteria.
Participation in patient case reviews with the hepatology team.

Week 5-6:
Therapeutic Approaches

Review of therapeutic modalities, including local and systemic treatments.
Observing and assisting in interventional procedures (TACE, RFA, etc.).
Learning about targeted therapy and immunotherapy options in advanced liver cancer.

Week 7-8:
Clinical Trials and Research

Immersive experience in ongoing clinical trials: protocol adherence, patient enrollment, and data management.
Developing skills in writing clinical trial protocols.
Reviewing ethical and regulatory requirements for trials in hepatology.

Week 9-10:
Multidisciplinary Management

Active participation in tumor boards and interdisciplinary meetings.
Integrating medical, interventional, and surgical management plans for complex cases.
Case study presentations by fellows.

Week 11-12:
Capstone and Future Directions

Final presentation by fellows on a selected research topic or case study.
Feedback sessions with Dr. Bouattour and senior consultants.
Exploring future research opportunities and collaborations.

Accommodation

Try airbnb.com

Fees and Program Logistics

This program has the following durations available:

Duration	Fee
2 weeks	$1,000.00
4 weeks	$1,500.00
8 weeks	$2,750.00
12 weeks	$3,750.00

This program allows Merit Applications. If you successfully are awarded a merit application - Trialect will take care of all bench and service fees, but you will have to take care of travel and accommodation. All applications will be scrutinized under the merit category. Considering 50 million health professionals around the world, the chances of getting selected under the merit category would be very low.

Who Can Apply

Hepatologists, Gastroenterologists, Digestive Oncologist, Liver Pathologist; liver surgeon,s and Radiologists involved in the management in liver diseases and liver cell cancers can participate

Host Details

Host Name: Dr Mohamed BOUATTOUR

Affiliation: Hôpital BEAUJON

Address: 100 Boulevard du Général Leclerc 92110 Clichy, FRANCE

Website URL: https://lefoie.org/

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.